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Abstract
The Locus Control Region (LCR) requires intronic elements within b-globin transgenes to direct high level expression at all
ectopic integration sites. However, these essential intronic elements cannot be transmitted through retrovirus vectors and
their deletion may compromise the therapeutic potential for gene therapy. Here, we systematically regenerate functional b-
globin intron 2 elements that rescue LCR activity directed by 59HS3. Evaluation in transgenic mice demonstrates that an Oct-
1 binding site and an enhancer in the intron cooperate to increase expression levels from LCR globin transgenes.
Replacement of the intronic AT-rich region with the Igm 39MAR rescues LCR activity in single copy transgenic mice.
Importantly, a combination of the Oct-1 site, Igm 39MAR and intronic enhancer in the BGT158 cassette directs more
consistent levels of expression in transgenic mice. By introducing intron-modified transgenes into the same genomic
integration site in erythroid cells, we show that BGT158 has the greatest transcriptional induction. 3D DNA FISH establishes
that induction stimulates this small 59HS3 containing transgene and the endogenous locus to spatially reorganize towards
more central locations in erythroid nuclei. Electron Spectroscopic Imaging (ESI) of chromatin fibers demonstrates that
ultrastructural heterochromatin is primarily perinuclear and does not reorganize. Finally, we transmit intron-modified globin
transgenes through insulated self-inactivating (SIN) lentivirus vectors into erythroid cells. We show efficient transfer and
robust mRNA and protein expression by the BGT158 vector, and virus titer improvements mediated by the modified intron
2 in the presence of an LCR cassette composed of 59HS2-4. Our results have important implications for the mechanism of
LCR activity at ectopic integration sites. The modified transgenes are the first to transfer intronic elements that potentiate
LCR activity and are designed to facilitate correction of hemoglobinopathies using single copy vectors.
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Introduction
The b-globin gene is regulated by a Locus Control Region
(LCR) that interacts with gene proximal elements to activate
erythroid specific expression. Many studies demonstrate that
individual LCR hypersensitive sites (HS) loop out the intervening
DNA to interact with the globin genes [1–4], and that
transcriptional activation is accompanied by movement of the
gene away from heterochromatin at the nuclear periphery towards
transcription factories located more centrally [5–8]. While the
LCR is not required to establish open chromatin at the
endogenous locus [9], it is able to open chromatin at ectopic b-
globin transgene integration sites to activate high level transcrip-
tion [10–12]. This ability of the LCR, in particular its 59HS3
element [13], to open chromatin at all integration sites has made it
a widely used component of gene therapy expression cassettes
designed for treatment of b-thalassemia or Sickle Cell Anemia.
Several groups have corrected these diseases in mouse models
using lentivirus mediated delivery of LCR b-globin vectors
regulated, at least in part, by 59HS3 [14–21].
One current limitation to LCR b-globin gene therapy cassettes
is that high titer virus transmission requires the deletion of AT-rich
(ATR) sequences in b-globin intron 2 [22,23]. We have shown that
these intronic ATR sequences are required for LCR activity by
59HS3 when assayed in transgenic mice [24]. These data indicate
that LCR b-globin sequences used in gene therapy cassettes may
compromise chromatin opening and transcriptional enhancement
activities. Thus, vectors containing the ATR deletion may require
more than 1 integration per cell to ensure expression, as has been
observed during gene therapy [25,26]. Although increased vector
copy number will direct therapeutic levels of expression, it also
increases the likelihood of insertional activation of surrounding
oncogenes [27]. In order to reduce potential genotoxicity, it would
be advantageous to include insulator elements in the LTRs to
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number load by redesigning the expression cassette to function
more effectively [33].
To design improved expression cassettes, we dissected the ATR
to discover functional elements that are not included in gene
therapy cassettes [24]. The ATR contains binding sites for the
erythroid specific factor Gata-1 and the ubiquitous factor Oct-1
[34,35]. Mutation of these sites showed that Oct-1 is required for
high level expression by 59HS3 b/c-globin hybrid transgenes,
while the Gata-1 mutation had no effect [34]. The significance of
Oct-1 on b-globin expression was further demonstrated in Oct-1
deficient mice generated by gene targeting [36], suggesting that an
Oct-1 site should be incorporated into b-globin gene therapy
cassettes.
The sequence within the ATR responsible for functionally
interacting with 59HS3 to open chromatin is unknown. A
candidate element for this role is the Matrix Attachment Region
(MAR) that overlaps the ATR [37,38] but is deleted from gene
therapy cassettes [22,23]. This MAR contains 2 SATB1 (Special
AT-Rich Binding-1) binding sites [35], and SATB1 is required for
e-globin expression in primitive erythroid cells [39]. We noticed
that the 39MAR in the immunoglobulin m (Igm) locus is also
located in an intron and contains 3 SATB1 sites [40]. Importantly,
the Igm 39MAR is able to transmit through a lentivirus and
provides position independent expression in primary B lympho-
cytes [41]. These findings suggest that the Igm 39MAR might
perform the same function when substituted for the b-globin ATR,
and that this function could then be transmitted through a
lentivirus vector.
Here, we introduce an Oct-1 consensus site and the Igm 39MAR
into 59HS3 b/c-globin hybrid transgenes in which the ATR has
been deleted. We show that the Oct-1 site cooperates with the b-
globin intronic enhancer to increase expression levels in transgenic
mice. The Igm 39MAR rescues LCR activity by 59HS3 in single
copy transgenic mice, and the combination of both an intronic
Oct-1 site and Igm 39MAR in the BGT158 construct gives high
expression levels nearly equivalent to those directed in the
presence of the complete ATR. At a specific integration site in
erythroid cells, the BGT158 construct is most responsive to
transcriptional induction and spatially reorganizes into the nuclear
interior. The endogenous b-globin locus also moves internally
while ultrastructural heterochromatin organization remains pri-
marily peripheral. Insulated lentivirus can be generated for all the
59HS3 constructs with BGT158 giving the highest protein and
RNA expression in erythroid cells. In addition, the modified
BGT158 intron 2 increases the titer of vectors containing a larger
LCR cassette (59HS4, 59HS3 and 59HS2), although it is not
essential for high level expression in this context. Overall, our data
demonstrate the importance of an intronic Oct-1 site and MAR
element to potentiate LCR activity by 59HS3, show that a 59HS3
b/c-globin transgene undergoes normal nuclear relocalization
during erythroid cell maturation, and provide evidence that
modified introns are compatible with efficient lentivirus transduc-
tion resulting in robust Ac-globin expression.
Results
Novel LCR b/c-Globin Hybrid Transgenes with Intronic
Oct-1 and MAR Elements
We previously showed that the BGT64 transgene (Figure 1A)
with a deletion of the 372 bp ATR directed reduced mean per
copy expression of 31% and did not express at all integration sites
in transgenic mice [24]. In contrast, the BGT50 transgene
(Figure 1A) that contains the ATR expressed at all integration
sites to a mean level of 64% per copy [24]. Since specific mutation
of the Oct-1 site alone in the BGT131 transgene reduced mean
expression to 31% but allowed expression at all sites [34], we
reasoned that the Oct-1 site is important for high level expression
and that some other component of the ATR functionally interacts
with 59HS3 LCR activity to direct expression at all integration
sites. To create transgenes that more consistently express to high
levels for use in virus vectors, we sought to reinsert a consensus
Oct-1 site and a MAR element into the BGT64 transgene. In
brief, BGT64 is composed of an 850 bp 59HS3 element, the 815
bp b-globin promoter linked to Ac-globin coding sequence and a
downstream 260 bp b-globin 39 enhancer. It also contains a b-
globin intron 2 with the 372 bp ATR deletion (Figure 1). BGT64
encodes an Ac-globin protein with 3 amino acids corresponding to
b-globin due to coding sequences that flank b-globin intron 2.
To create improved transgenes, we first used site directed
mutagenesis in order to encode completely wild-type Ac-globin
protein. We then introduced a consensus Oct-1 site and/or the Igm
39MAR element back into the site where the ATR was deleted. To
determine if the b-globin intronic enhancer is functionally
important, we inserted the Oct-1 site into the Ac-globin intron 2
that lacks an enhancer in the BGT54 transgene (which also
encodes completely wild-type Ac-globin protein). Overall, 3
constructs were generated (Figure 1) to test if the Oct-1 site
increases expression (BGT144) and cooperates with the intronic
enhancer (BGT145,147). In addition, BGT156 was constructed to
test the ability of the Igm 39MAR to rescue LCR activity by 59HS3
at single copy integration sites, and BGT158 was used to examine
whether the presence of both the Oct-1 site and Igm 39MAR
results in more consistently high transgene expression.
To test the effect of these intronic modifications on expression
by 59HS3 b/c-globin hybrid transgenes, they were microinjected
into fertilized FVB mouse eggs. Fetuses were collected at day 15.5
and transgenic animals identified by DNA slot blot analysis.
Southern blot analysis on fetal liver DNA determined transgene
copy number, intactness and mosaicism (data not shown). Animals
containing copy numbers .35, or mosaic animals containing
,25% transgenic cells in the fetal liver, were excluded. Multicopy
animals are sufficient for the purpose of defining mean per copy
expression levels directed by the Oct-1 site since it is not required
Author Summary
Expression of the b-globin gene is regulated by interac-
tions between a distant Locus Control Region (LCR) and
regulatory elements in or near the gene. We previously
showed that LCR activity requires specific b-globin intron
elements to consistently activate transgene expression in
mice. These important intronic elements fail to transmit
through lentivirus vectors designed for gene therapy of
Sickle Cell Anemia. In this study, we identify intron
modifications that reveal functional cooperation between
the b-globin intronic enhancer and an intronic Oct-1 site.
LCR activity in transgenic mice is also potentiated by an
intronically located Igm 39MAR element. During induction
of erythroid gene expression, the modified intron directs
relocalization of the transgene away from the nuclear
periphery towards more central neighbourhoods, and this
movement mimics relocalization by the endogenous b-
globin locus. Lentivirus vectors with the modified intron
produce high titer virus stocks that express the transgene
to therapeutic levels in erythroid cells. These findings have
implications for understanding the mechanism of LCR
activity, and for designing safe and effective lentivirus
vectors for gene therapy.
Intron Elements Potentiate LCR Activity
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the Igm 39MAR requires analysis of at least 3 independent single
copy mice.
Oct-1 Site Rescues Expression Levels
A total of 9 transgenic animals were identified with intact
BGT144 transgenes, ranging in copy number from 1 to 15. qRT-
PCR was performed on fetal liver RNA to determine expression
levels of the transgene relative to endogenous mouse bmajor-
globin (Figure 2A). As controls for the accuracy of the RT-PCR
reactions, a previously analyzed BGT64 sample (+ve) that
expressed at 23% per mouse bmajor-globin gene by S1 nuclease
assay [24] and a non-transgenic (Ntg) sample were analyzed.
BGT144 animals express the transgene to a mean per copy level of
78% 624 (SE). These results are significantly different from
previous BGT64 results (P=0.05 by two-sided Mann-Whitney
test) and demonstrate that the Oct-1 site rescues mean expression
levels from transgenes that lack the ATR.
Oct-1 Site Cooperates with the Intronic Enhancer
To evaluate whether the Oct-1 site cooperates with the intronic
enhancer to rescue expression levels, transgenic animals were
Figure 1. Maps of LCR b/c-globin transgene constructs with intronic insertions of a consensus Oct-1 site or the Igm 39MAR element.
(A) The BGT50 cassette is comprised of 59HS3, b-globin promoter, Ac-globin exons 1-3, b-globin intron 2 (bIVS2) containing the AT-rich region (ATR)
and intronic enhancer, and the 39 b-globin enhancer. The BGT64 cassette contains the 372 bp ATR deletion. (B) Intronic modifications generated in
the LCR b/c-globin transgenes. BGT144 contains an Oct-1 site in place of the deleted ATR along with the intronic enhancer. BGT145 has an Oct-1 site
in the Ac-globin intron 2. BGT147 contains the Oct-1 site and intronic enhancer in a hybrid intron with 59 Ac-globin and 39 b-globin sequences.
BGT156 contains the Igm 39MAR in place of the deleted ATR along with the intronic enhancer. BGT158 contains the Oct-1 site 59 of the Igm 39MAR in
place of the deleted ATR and the intronic enhancer.
doi:10.1371/journal.pgen.1000051.g001
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transgenic animals were identified with intact BGT145 transgenes
ranging in copy number from 1 to 30. qRT-PCR analysis showed
that BGT145 animals express the transgene to a mean per copy
level of 10% 68 (Figure 2B). These data suggest that Oct-1 does
not rescue expression levels when inserted into an Ac-globin intron
2 that lacks an intronic enhancer. The BGT147 transgene
contains a hybrid intron that includes the b-globin intronic
enhancer (Figure 2C). Five transgenic animals were identified with
intact BGT147 transgenes ranging in copy number from 1 to 5.
qRT-PCR demonstrated that BGT147 animals express the
transgene to a mean per copy level of 68% 618 with a significance
of P=0.01 (Figure 2C). These data confirm that the Oct-1 site
cooperates with the intronic enhancer to increase expression levels,
even within the context of a hybrid intron 2.
Igm 39MAR Rescues LCR Activity but with Variable
Expression
To test if replacement of the b-globin ATR with the Igm 39MAR
rescues LCR activity in single copy transgenic mice, the BGT156
cassette was generated. Three single copy transgenic animals were
identified with intact BGT156 transgenes, but no multicopy
animals were obtained. The BGT156 single copy animals express
the transgene to a mean per copy level of 74% 634 (Figure 3A)
but with quite variable expression output (range 12–131%). These
results indicate that the Igm 39MAR rescues 59HS3 directed LCR
activity at single copy.
Oct-1 Site and Igm 39MAR Direct Consistent Expression
To test if introduction of the Oct-1 site upstream of the Igm
39MAR helps direct more consistently high Ac-globin expression,
the BGT158 construct was evaluated. Five transgenic animals
were identified with intact BGT158 transgenes ranging in copy
number from 2 to 18. As controls for the accuracy of the PCR
reactions, a previously analysed BGT50 homozygous fetal liver
sample (+ve) that expressed at 40% per mouse bmajor-globin gene
by S1 nuclease assay was used [24]. BGT158 animals express the
transgene to a mean level of 53% 611 with a significance of
P=0.01 (Figure 3B). These findings suggest that the BGT158
transgene directs high levels of consistent expression regardless of
the integration site. Activities associated with the Oct-1 site, Igm
39MAR and intronic enhancer contribute to this effect. Because no
single copy animals were identified with the BGT158 construct to
directly compare its expression with the single copy BGT156
animals, we proceeded to insert single copies of both these
constructs into the same genomic site in Mouse Erythroleukemia
(MEL) cells.
Integration and Induction of LCR b/c-Globin Transgenes
at the Same Genomic Site
We took advantage of the FLP recombinase system to direct
insertion of BGT156, BGT158 and BGT64 as a control into the
same FRT site in MEL cells (Figure 4A). The BGT50 transgene
had previously been inserted into this same site [42]. Proper
integration at the FRT site was verified for 2 independent
BGT156, BGT158 and BGT64 MEL cell clones by Southern blot
analysis using a LacZ probe (Figure 4B). Digestion with EcoRI
which cuts MEL acceptor genomic DNA downstream of LacZ
detected a single band of 5.5 kb in the MEL acceptor cell line. The
BGT50 cell line has an additional EcoRI site in the 59HS3 b/c-
globin hybrid sequence and produced the expected single 4.6 kb
band. Two additional flanking EcoRI sites were introduced during
subcloning of BGT156, BGT158 and BGT64 into the SFV
plasmid resulting in detection of a common 3.7 kb band by the
LacZ probe. Intactness of 59HS3 b/c-globin sequences and single
site insertion was verified with the BstR probe and the internal
HS3 probe that reveal the expected band sizes, with the 59HS3
Figure 2. The Oct-1 site increases LCR b/c-globin transgene
expression by cooperating with the intronic enhancer. (A) RNA
expression analysis using qRT-PCR on fetal liver tissue from BGT144
transgenic animals. The mean expression per transgene from qRT-PCR
performed in triplicate for BGT144 is 78% 624 (standard error-SE). (B)
qRT-PCR results from BGT145 transgenic animals show that mean
expression per transgene is 10% 68. C) qRT-PCR results from BGT147
transgenic animals show that mean expression per transgene 68% 618.
In each case, the amount of product from amplification reactions with a
primer set specific for the human b/c-globin transcript was scaled
relative to 10
4 molecules from amplification reaction with primers
specific for the mouse bmajor-globin gene. The positive control (+ve) is
a previously published BGT64 sample (FF334) and the negative control
(Ntg) is a nontransgenic animal.
doi:10.1371/journal.pgen.1000051.g002
Intron Elements Potentiate LCR Activity
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(Figure 4B). Together these data demonstrate that integration of
the transgenes occurred at the FRT site with no randomly
integrated vector DNA.
To assess expression of Ac-globin in these cell lines, we
measured RNA levels before and after induction with 5 mM
HMBA. RNA was obtained from the 2 independent cell clones for
each construct and subjected to qRT-PCR in triplicate. Expres-
sion of Ac-globin transcripts was normalized to PolII large subunit
transcripts. After induction for 3 days, the mean amount of
BGT64 RNA increased just 2.6 fold while BGT50 and BGT158
RNA increased 9 fold and 18 fold respectively (Figure 5A). In
contrast, BGT156 transcripts increased just 4 fold, due to
relatively high levels of transcripts in the uninduced cells. These
data indicate that BGT156 expresses prematurely at this
integration site. In contrast, the greater fold RNA induction of
BGT158 reflects its low expression in uninduced cells. To ensure
equivalent induction quality for the different cell lines, flow
cytometry was performed at day 6 to allow accumulation of Ac-
globin protein (Figure 5B). This analysis demonstrates that
uninduced BGT50 and BGT158 cells do not express Ac-globin
protein, but 7–8% of BGT64 and BGT156 cells are Ac-globin
positive which is consistent with the RNA analysis. After
induction, the BGT156 and BGT158 constructs express Ac-
globin protein to similar levels. These results demonstrate that the
BGT158 construct is more finely regulated than BGT64 and
BGT156 at this integration site.
Nuclear Relocalization of the BGT158 Transgene during
MEL Cell Induction
To determine whether 59HS3 b/c-globin transgenes are
properly localized within the nucleus, we performed three-
dimensional DNA FISH (fluorescent in-situ hybridization) with
and without 3 days of HMBA induction. We chose the MEL
BGT158 cells for this analysis because they have the greatest
induction of RNA over this period. To detect the BGT158
transgene by FISH, the 10 kb SFV plasmid used for FRT site-
specific insertion was labeled with digoxigenin (DIG) and the
probe signal was amplified using Alexa Fluor 546 labelled
tyramide [43]. FISH signals were detected on BGT158 transgenes
(see 3D reconstruction in Video S1), but not in the MEL acceptor
cell line containing the FRT site (data not shown). Measurements
of the mean radial distribution of BGT158 transgenes in .80
nuclei from each of 3 experiments were binned into 5 radial shells
extending from shell 1 at the periphery to shell 5 at the centre
(Figure 6A and 6B). The z-sections used for these measurements
had the same average nuclear diameter in both the uninduced and
induced samples. In uninduced cells, the majority of BGT158
transgenes (54%) are detected in shell 2, near but not at the
nuclear periphery. After HMBA induction, BGT158 transgene
localization in shell 2 falls to 37% with a concomitant increase in
its frequency in more internal shells. Due to the high cumulative
n=250 nuclei from 3 separate experiments, these results are
significant at P,0.001 by two-sided Mann-Whitney test. At the
same time we measured transgene proximity to the nearest DAPI-
rich heterochromatin. Approximately 62% of BGT158 transgene
signals are within 1 mm of DAPI-rich heterochromatin in the
uninduced state, but HMBA induction only slightly reduces this
proximity to 51% (Figure S1). To confirm that radial relocaliza-
tion is dependent on BGT158 sequences and is not a consequence
of the FRT integration site, we repeated the experiment using a
3.0 kb LacZ fragment as probe on the original MEL acceptor cell
line. In this case there was no relocalization after induction with
greater than 50% of the signal remaining in shell 2 (P=0.92)
(Figure 6A). These data document relocalization of the BGT158
transgene towards more internal nuclear positions during globin
gene induction. To extend these results, relocalization of the
globin transgene was tracked using the same 3D DNA FISH
probe in BGT64 and BGT156 cells (Figure 6C and 6D). In the
absence of the intron 2 ATR, the BGT64 transgene preferentially
localized to shell 2. After induction there was a slight reduction
in shell 2 occupation but without any obvious preference for
moving internally (P=0.35). BGT156 transgenes localized in
shells 1 and 2 before moving internally into shells 2 and 3 upon
induction (P=0.04). We conclude that the intron 2 ATR
contributes to nuclear relocalization during erythroid induction.
The presence of the Igm 39MAR alone facilitates a less pronounced
relocalization during induction than observed with the BGT158
construct.
Figure 3. The Igm 39MAR rescues LCR activity but consistent
expression levels requires the Oct-1 site. (A) qRT-PCR results from
BGT156 transgenic animals show mean expression per transgene is 74%
634. (B) qRT-PCR results from BGT158 transgenic animals show mean
expression per transgene is 53% 611. All samples analyzed as described
in Figure 2, with the exception that the positive control (+ve) in BGT158
is fetal liver RNA from a previously characterized bred homozygous
BGT50 mouse line.
doi:10.1371/journal.pgen.1000051.g003
Intron Elements Potentiate LCR Activity
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during MEL Cell Induction
To determine whether the endogenous mouse b-globin locus
also relocalizes from the periphery to more central locations upon
induction, we performed 3D DNA FISH with a BAC probe but
without tyramide amplification (Figure 7A and 7B). This analysis
detected a preference for shells 1 and 2 and movement into more
interior shells after induction (P,0.001). This movement of the
endogenous b-globin locus is similar to the movement of the
BGT158 transgene, and when induced they both resemble the
localization of the endogenous mouse b-globin locus in fetal liver
cells at stage 3 (CD117-, Ery1+, Ter119+) of erythroid
development [8]. Flow cytometry demonstrates that uninduced
MEL cells are CD117-, Ery1
lo, CD71+ and Ter119- (Figure S2).
This may represent the stage 2/3 transition where CD117 has
turned off, Ery1 is activated to some degree but Ter119 has not yet
turned on. Upon induction, MEL cells become CD117-, Ery1-,
CD71
lo but remain Ter119- and therefore cannot be directly
compared with the known Ter119+ late stages of erythroid
development.
Ultrastructural Organization of Heterochromatin during
MEL Cell Induction
To examine heterochromatin organization at the ultrastructural
level in single MEL cells, we performed Electron Spectroscopic
Imaging (ESI) [44]. This technique allows visualization of
chromatin fibers after electron microscopy of 70 nm cell sections.
We first examined the effect of 3 days HMBA induction on
nuclear volume in low magnification phosphorus enhanced mass
images (Figure 8A). While there is a range of diameters measured
in the random sections chosen, the average nuclear diameter of
induced cells is reduced by 24% compared to untreated controls
and thus the average nuclear volume is significantly smaller. This
size reduction could potentially result in a global compaction of
chromatin. To address whether the volume change leads to an
increase in the amount of condensed chromatin, we measured the
area of condensed chromatin along the nuclear envelope
(Figure 8B). These areas from each cell were normalized to the
perimeter corresponding to the area measured to provide a
measurement of compaction of chromatin along the nuclear
envelope. We found that there was a slight increase in the average
amount of peripheral heterochromatin, though this difference was
not statistically significant. The vast majority of the condensed
chromatin within these cells is located at the periphery, or adjacent
to the nucleolus, with a moderate subset localizing to the regions
surrounding the nucleolus. To represent the most extreme
differences in nuclear diameter, we chose to compare one of the
largest uninduced nuclei to one of the smallest induced nuclei
(Figure 8C–8F). Qualitative analysis of the high magnification
phosphorus (P) and nitrogen (N) images indicates that thickened
regions of condensed chromatin (CCh) along the nuclear envelope
are interspersed with regions where the condensed chromatin is
thinly represented (arrow) and where nuclear pores can be easily
visualized (arrowhead). The remainder of the chromatin through-
out the nucleoplasmic volume is represented by relatively
decondensed (DCh) and sparsely represented chromatin fibers.
The volume not represented by chromatin (blue) has decreased by
differentiation but the structural features of the decondensed and
the condensed chromatin is unaffected. Thus, the nuclear
Figure 4. Single copy integration of LCR b/c-globin transgenes into a specific FRT site in MEL acceptor cells. (A) Structure of the
transgene after targeted insertion in MEL cells showing the location of EcoRI (R1) restriction sites and the LacZ, BstR and HS3 probes (grey lines). MEL
acceptor DNA is cut 39 of LacZ, and BGT50 is cut 39 of LacZ and once within the b/c-globin sequence. Two additional EcoRI sites were introduced in
the 59 and 39 linkers during SFV vector subcloning of BGT64, BGT156, BGT158. (B) Southern blot analysis of genomic DNA cut with EcoRI.
Hybridization with LacZ, BstR and HS3 probes confirms intactness of the integrated constructs. Hybridization with BstR and HS3 probes detects no
band in the MEL acceptor cell line as expected, or a single band of the expected size for a single site transgene integration at the FRT site and the
absence of random integrations.
doi:10.1371/journal.pgen.1000051.g004
Intron Elements Potentiate LCR Activity
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conditions and transgene movement detected by 3D DNA FISH is
not the result of heterochromatin reorganization during MEL cell
induction.
Lentivirus Vector Construction and Expression in MEL
Cells
Given that BGT158 is properly regulated with normal nuclear
dynamics and high Ac-globin protein accumulation in MEL
acceptor cells, we proceeded to test whether it functioned better
than the other constructs in gene therapy vectors. As all the
constructs were designed to be transmitted through virus vectors,
we inserted them in the antisense orientation into a SIN lentivirus
vector containing a dimer core cHS4 insulator element in the
39LTR (Figure 9A). The BGT145 construct was excluded from
this analysis due its low level Ac-globin RNA expression in
transgenic mice (Figure 2B). These lentiviral vectors were
concentrated 250 fold by ultracentrifugation. To analyze expres-
sion of Ac-globin, MEL cells were infected with 4 to 40 mlo f
concentrated lentivirus and induced with 5 mM HMBA. DNA
and RNA samples were collected on day 3, with flow cytometry
performed in triplicate on day 6 to calculate titers of Ac-globin
protein expressing virus. Virus titers per ml from three
independent inductions were as follows: BGT144 (4.8610
6),
BGT147 (1.2610
6), BGT156 (3.8610
6) and BGT158 (1.1610
7).
Samples with approximately 20% Ac-globin expressing cells
containing roughly equal vector copy numbers are shown
(Figure 9B). This analysis reveals that BGT156 and BGT158
lentivirus express the highest levels of Ac-globin protein at 123 and
135 mean fluorescence units (MFI) respectively, while BGT144
and BGT147 express only 77 and 84 MFI.
To determine the amounts of Ac-globin transcripts in the
infected MEL cells, qRT-PCR was performed in triplicate relative
to 2610
4 mouse bmajor-globin molecules, after correction for
Figure 5. The BGT158 transgene responds with the highest fold induction in MEL cells. (A) qRT-PCR analysis of Ac-globin RNA expression
by MEL BGT64, MEL BGT156 and MEL BGT158 cell lines. Mean fold increase of RNA levels 6SE is shown on the third day after induction with 5 mM
HMBA calculated from triplicate qRT-PCR samples from 2 independent clones for each transgene. MEL and MEL BGT50 cell lines are negative and
positive controls respectively. (B) Flow cytometry with and without 6 days of HMBA induction shows the cell % expressing Ac-globin protein, and
demonstrates that all constructs produce roughly equivalent protein levels.
doi:10.1371/journal.pgen.1000051.g005
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PLoS Genetics | www.plosgenetics.org 7 April 2008 | Volume 4 | Issue 4 | e1000051Figure 6. Nuclear relocalization of the BGT158 transgene in MEL cells during HMBA induction. (A) Radial distribution of BGT158
transgene examined by 3D DNA FISH. The x-axis indicates percentage of the nuclear radius, in which 100-80% of the nucleus represents the periphery
and 20-0% represents the centre. Each condition was repeated in three individual experiments with at least 80 transgene signals scored for each
experiment. The data shown is the mean from all 3 experiments 6SE. (B) Examples of BGT158 transgene localization by 3D DNA FISH, with or without
HMBA induction. The z-section containing the transgene signal used for radial measurements is shown. The transgene is detected in red with DIG
labeled probe and tyramide signal amplication, and nuclear DNA is counterstained with DAPI (cyan). The number at the bottom of each panel
represents the radial location in the nucleus shown. (C) Radial distribution of BGT64 and BGT156 transgenes examined by 3D DNA FISH as described
in A above. BGT156 was repeated in three individual experiments with greater than 250 transgene signals scored. BGT64 was repeated in two
individual experiments with greater than 160 transgene signals scored for each experiment.
doi:10.1371/journal.pgen.1000051.g006
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actin gene. These results parallel the protein analysis, with higher
Ac-globin transcript levels detected for BGT156 and BGT158 at
0.99610
4 and 1.38610
4 molecules, in comparison to 0.74610
4
and 0.88610
4 molecules for BGT144 and BGT147 (Figure 9C).
Lentivirus copy numbers demonstrate that all vectors infected
between 23–30% of the cells (Figure 9D). As reported by others,
PCR amplification of the dimer core cHS4 in the LTRs shows that
it is reduced to a monomer after transduction (Figure S3). We
conclude that BGT158 is the most efficient vector because it
expresses the highest Ac-globin RNA and protein levels from the
lowest number of infected cells. Overall BGT158 lentivirus
transcripts are 65% the level of mouse bmajor-globin in MEL
cells.
Figure 7. Nuclear relocalization of the endogenous b-globin locus in MEL cells during HMBA induction. (A) Radial distribution of the
endogenous mouse b-globin locus examined by 3D DNA FISH as described in Figure 6. Each condition was repeated in three individual experiments
with greater than 250 transgene signals scored. (B) Examples of endogenous mouse b-globin locus localization by 3D DNA FISH, with or without
HMBA induction. Two z-sections from the same cell containing one FISH signal each are shown and were used for radial measurements. The
transgene is detected in red with DIG labeled BAC probe, and nuclear DNA is counterstained with DAPI (cyan). The number at the bottom of each
panel represents the radial location in the nucleus shown. Red scale bars indicate 2 mm.
doi:10.1371/journal.pgen.1000051.g007
Intron Elements Potentiate LCR Activity
PLoS Genetics | www.plosgenetics.org 9 April 2008 | Volume 4 | Issue 4 | e1000051Increased Titer by the BGT158 Intron and
Complementation by Other HS Elements
It has recently been reported that the 59HS4 element of the
LCR contributes to high expression levels in b-globin lentivirus
vectors and that the functional part of this element can be
substituted by the IFNb S/MAR in the absence of the intron 2
ATR [45]. To determine how the modified BGT158 intron 2
might influence expression of transgenes that also include 59HS4
and 59HS2, we generated insulated lentivirus vectors with the 3.0
kb BGT14 LCR [46] composed of 59HS4, 59HS3 and 59HS2
(Figure 10A). These vectors have different intron 2 compositions;
Figure 8. Nuclear organization of ultrastructural heterochromatin in MEL cells during HMBA induction. Electron Spectroscopic Imaging
(ESI) analysis of undifferentiated and three-day differentiated MEL cells. (A) The average diameter of undifferentiated MEL cells changes upon HMBA
differentiation. The diameters of sectioned cells were measured as described in the methods section. (B) The change in size is correlated to a small
and statistically insignificant change in peripheral heterochromatin distribution after differentiation. Low magnification phosphorus enhanced mass
images of a large undifferentiated nucleus (C) and a small differentiated (E) nucleus. Higher-resolution element specific ratio maps were acquired of
regions of interest indicated by white boxes. Phosphorus element specific ratio maps were pseudo-coloured yellow and overlaid onto phosphorus
subtracted nitrogen maps pseudo-coloured cyan. Phosphorus containing chromatin appears yellow and protein-rich regions are blue. An example of
condensed chromatin regions are indicated (CCh) in both the undifferentiated (D) and differentiated (F) cells as is a decondensed region (DCh), the
nucleolus is demarked by Nu and nuclear pores with a bold arrowhead and thinly represented condensed chromatin at the envelope with a white
arrow.
doi:10.1371/journal.pgen.1000051.g008
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contains the intron 2 ATR deletion from BGT64, and BGT161
contains the modified BGT158 intron 2. Infections of MEL cells
with 4 to 40 ml of virus were performed for comparison with the
BGT158 lentivirus. Flow cytometry for Ac-globin expression
(Figure 10B) demonstrates that BGT159 fails to make significant
virus titers per ml (,6610
4) as expected for the wild-type intron 2.
In contrast, BGT160 and BGT161 produce high and roughly
equivalent levels of Ac-globin protein (MFI 270 and 239) that
exceed the levels from BGT158 (MFI 119), suggesting that 59HS4
or 59HS2 can compensate for the absence of the intron 2 ATR.
Nevertheless, the titer of the BGT158 virus is much greater
(1.4610
7) than BGT160 (5.2610
5). The presence of the modified
intron 2 in BGT161 increased the titer to 2.3610
6. With respect to
RNA levels (Figure 10C), the sample infected with 4 ml of BGT158
virus produced 1.54610
4 Ac-globin molecules (75% of mouse b-
globin), while 40 ml of BGT160 produced 0.97610
4 (48%) and
10 ml of BGT161 produced 0.81610
4 molecules (40%). DNA
analysis reveals a precise correspondence between provirus
content (Figure 10D) and the percentage of expressing cells
(Figure 10B). We conclude that the larger LCR cassette can
compensate for the absence of the intron 2 ATR in MEL cells, but
that the modified BGT158 intron 2 increases the titer of viruses
with the larger LCR. In summary, the use of this modified intron 2
in 59HS3 and larger LCR constructs including 59HS4 and 59HS2
should facilitate consistent expression at single vector copy during
gene therapy of hemoglobinopathies.
Discussion
LCR b-globin transgenes used for gene therapy of hemoglobin-
opathies contain a deletion in intron 2 that removes functionally
important ATR sequences and may compromise expression. Here
we regenerate the intron and demonstrate the ability of these
Figure 9. Insulated SIN lentivirus vectors containing 59HS3 b/c-globin transgenes express in MEL cells. (A) Map of the PL.SIN.cHS4
lentivirus showing the HIV 59LTR, cppt, RRE, 59HS3 b/c-globin transgene and the 400 bp SIN deletion of the 39LTR bearing the dimer core cHS4
Insulator. (B) Lentivirus vectors containing the intronic Igm 39MAR express the highest mean Ac-globin protein levels assessed by flow cytometry of
MEL cells infected at low MOI. Data with approximately 20% Ac-globin protein expressing cells is shown by flow cytometry performed in triplicate
6SE after 6 days induction with HMBA. (C) Lentivirus vectors containing the intronic Igm 39MAR express the highest Ac-globin RNA levels. qRT-PCR
results in triplicate 6SE were performed on the 20% protein positive infected MEL cells after 3 days induction with HMBA. RNA expression is shown
as Ac-globin molecules per 2610
4 mouse bmajor-globin molecules after correction for the lentivirus copy number. (D) The lentivirus copy number is
approximately equal in each infection. qPCR analysis of lentivirus copy number 6SE in the MEL cell genome. The number of transgene molecules was
determined by amplification with 39 b-globin enhancer primers and plotted versus 200 mouse b-actin molecules. These data correspond to the % of
infected MEL cells.
doi:10.1371/journal.pgen.1000051.g009
Intron Elements Potentiate LCR Activity
PLoS Genetics | www.plosgenetics.org 11 April 2008 | Volume 4 | Issue 4 | e1000051transgenes to transmit through an insulated SIN lentivirus vector.
Using different combinations of intronic elements, we show that the
Oct-1 site cooperates with the b-globin intronic enhancer to raise
the mean level of expression in transgenic mice, and that the Igm
39MAR can functionally interact with 59HS3 to direct LCR activity
at single copy integration sites. The BGT158 construct containing
all of these elements shows good induction in erythroid cells with
normal nuclear relocalization dynamics. Moreover, BGT158
transmits at high titer through lentivirus vectors and expresses
robust Ac-globin levels in erythroid cells. These findings have
implications for understanding the mechanism of LCR activity at
ectopic transgene integration sites, and for designing lentivirus
vectors with minimal genotoxicity risk for gene therapy.
Oct-1 Site Cooperates with the Intronic Enhancer To
Rescue Expression Levels
To create transgenes that express highly and transmit through
viral vectors, we inserted a consensus Oct-1 site into intron 2 of
59HS3 b/c-globin constructs that lack the ATR. The BGT144
Figure 10. Increased titer by the BGT158 intron 2 and complementation by other HS elements. (A) Map of the PL.SIN.cHS4 lentivirus
showing the LCR (59HS2-4) b/c-globin transgene and other components described in Figure 9. BGT159 contains the wild-type intron 2 from BGT50,
BGT160 contains the BGT64 intron 2 with the deleted ATR (Figure 1A), and BGT161 contains the BGT158 modified intron 2 (Figure 1B). (B) The
presence of 59HS4 and 59HS2 compensates for the absence of the intron 2 ATR in BGT160. BGT160 expresses high mean Ac-globin protein levels
assessed by flow cytometry of MEL cells performed in triplicate 6SE after 6 days induction with HMBA. The presence of the BGT158 modified intron 2
in BGT161 increases the viral titer but not the MFI. (C) qRT-PCR results in triplicate 6SE were performed on the infected MEL cells after 3 days
induction with HMBA. RNA expression is shown as Ac-globin molecules per 2610
4 mouse bmajor-globin molecules after correction for the lentivirus
copy number. (D) The lentivirus copy number (detected by qPCR analysis as described in Figure 9D) is approximately equal to the % of Ac-globin+
cells detected by flow cytometry.
doi:10.1371/journal.pgen.1000051.g010
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per copy level of 78% 624 and 68% 618 respectively. These
results demonstrate the functional importance of the Oct-1 site in
rescuing expression levels in the presence of the intronic enhancer.
This conclusion is consistent with our previous observation that
mutation of the Oct-1 site alone in the BGT131 transgene reduces
expression levels [34]. However, the BGT145 construct contains
the Oct-1 site in an Ac-globin intron 2 that lacks an enhancer, and
mean per copy transgene expression was reduced to 10% 68.
These findings strongly indicate that the Oct-1 site alone is not
sufficient to activate high expression. We conclude that the Oct-1
site must cooperate with the intronic enhancer. This enhancer is
composed of three Gata-1 sites that form a DNaseI hypersensitive
site in erythroid cells [47]. Since both Oct-1 and Gata-1 can act as
either transcriptional activators or repressors depending on the
context [48–50], one interpretation of our results is that the
transgene has reduced activation or may even be actively repressed
when only one of the factors is bound to the intron.
Igm 39MAR Potentiates 59HS3 LCR Activity at Single Copy
To test the functional importance of a MAR in LCR activity, we
generated a construct in which the ATR is replaced by the Igm
39MAR. Expression from 3 of 3 single copy BGT156 mice at a
mean per copy level of 74% 634 demonstrates that the Igm 39MAR
functionally interacts with 59HS3 to direct LCR activity at ectopic
integrationsites. This ability to open chromatin does not require the
Oct-1 site, and is consistent with expression from 3 of 3 single copy
BGT131 transgenic mice and 7 of 7 single copy BGT133 animals in
which the Oct-1 site is mutated but the b-globin intron 2 MAR is
intact [34]. However, BGT131 and BGT133 mean per copy
expression falls to 31–37%, indicating that the Igm 39MAR is a
stronger positive element than the b-globin intron 2 MAR. The Igm
39MAR has 3 SATB1 binding sites and promotes extension of open
chromatin from the adjacent Igm enhancer [51]. SATB1 acts as a
landing platform for chromatin remodeling factors [43,52],
mediates DNA looping [53,54], and has been implicated in e-
globin gene regulation [39]. Since the Igm 39MAR and the b-globin
intron 2 MAR have similar locations near intronic enhancers and
are bound by SATB1, it is likely that they perform similar functions
in extending open chromatin to potentiate enhancer or LCR
function. Both of these MARs lie in regions that influence initiation
of DNA replication and its timing may be associated with the
chromatin state [55,56], or they could participate in DNA looping
events that accompany gene activation [57]. For example, 3C
results show that in the Activated Chromatin Hub 59HS3 loops to
interact with a region in the b-globin gene that is not the promoter
[4], and MARs or HS that flank the b-globin locus may also
contribute to Chromatin Hub formation in progenitor cells [38,58].
It is important to acknowledge that other factors bind to the Igm
39MAR and may contribute to its stronger activity in the context of
59HS3 b/c-globin transgenes [59].
In our final BGT158 construct, we added the Oct-1 site to the
Igm 39MAR and obtained mean per copy expression of 53% 611.
Thus, BGT158 expression is more consistent (range 22–90%) but
its mean per copy level is less than BGT156. These results suggest
that the combination of the Oct-1 site and intronic enhancer
moderates the activity of Igm 39MAR at ectopic sites in erythroid
cells. At the immunoglobulin locus, the Igm 39MAR is also
adjacent to an intronic enhancer that contains an Oct-1 site [40].
BGT158 Transgene Relocalizes to the Nuclear Interior
during Transcriptional Induction
To compare BGT156 and BGT158 transgene activity at the
same single copy integration site, we inserted them into a specific
FRT site in erythroid cells. Analysis of transcriptional induction
demonstrated that the BGT156 transgene is prematurely ex-
pressed and therefore induces only 4 fold, while the BGT158
construct has an 18 fold response. These data indicate that the
Oct-1 site in BGT158 also moderates the Igm 39MAR in
uninduced erythroid cells leading to more precise regulation. b-
globin induction in MEL cells correlates with increasing levels of
the NF-E2 erythroid specific factor [60] which binds just outside
the 59HS3 core but in the 59HS2 core [61,62]. NF-E2 is
implicated in relocation of 59HS2 regulated b-globin genes to
the nuclear interior upon MEL cell induction [60] and may
repress the LCR in uninduced cells [63]. Induction of BGT158
shows that 59HS3 regulated transgenes also perform normal
nuclear relocalization that resembles movement of the endogenous
b-globin locus. However, BGT158 movement away from DAPI-
rich heterochromatin is not as pronounced as that reported with
59HS2 regulated genes. This difference may reflect that 59HS3
does not have the strong enhancer activity present in 59HS2 that is
responsible for movement away from heterochromatin [7]. This
NF-E2 enhancement activity is not required to form the ACH
[64]. In contrast, Gata-1 and EKLF factors that bind the 59HS3
core do participate in ACH formation [65,66]. Current models of
LCR function suggest that movement to the nuclear interior by
the 59HS3 transgenes may reflect preferred engagement domains
with transcription factories [6,8]. Our ESI experiments demon-
strate that the nuclear interior is rich in ultrastructural euchro-
matin and that heterochromatin located at the periphery does not
reorganize during MEL cell differentiation.
Transgene and Lentivirus Vector Design for Gene
Therapy
The BGT158 transgene is a novel construct designed to
investigate LCR activity and for use in gene therapy. It is
optimized to express wild-type Ac-globin protein while incorpo-
rating functional intronic elements that cooperate to rescue
expression levels and LCR activity from 59HS3. To minimize
potential genotoxicity, we inserted BGT158 into a cHS4 insulated
SIN lentivirus vector. Infections performed at low MOI demon-
strate that it expresses highly in erythroid cells, and confirm that
the Igm 39MAR is able to transmit efficiently through lentivirus
vectors [41]. In the context of the larger LCR element that
includes 59HS4, 59HS3 and 59HS2, the modified BGT158 intron
2 is not essential for high level protein expression in MEL cells. As
59HS4 may contain a MAR element, this activity may functionally
compensate for the intron 2 MAR [45]. Nevertheless, the modified
intron 2 raised the titer of both the 59HS3 and larger LCR cassette
vectors. Our prior single copy transgenic mouse data indicates that
59HS3 regulated transgenes [24] express to higher levels in vivo
than LCR cassettes containing 59HS4, 59HS3 and 59HS2 [46] but
not as highly as with all four HS [12]. These data suggest that it
will be important to compare the utility of the modified intron 2 in
59HS3 and larger LCR cassette vectors [45] in the in vivo
environment of bone marrow transplantation in preclinical models
of hemoglobinopathy.
Methods
Plasmid Construction and Generation of Transgenic Mice
Intron modifications were performed largely by PCR as
described in the Supplementary Methods (Text S1 and Table
S1). All introns were reconstructed as BamHI-EcoRI fragments that
were inserted into the BamHI-EcoRI sites flanking intron 2 in
BGT64. To generate transgenic mice, the constructs were isolated
as ClaI fragments and purified using Elutip-d columns (Schleicher
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in injection buffer (10 mM Tris-HCl pH 7.5, 0.2 mM EDTA) and
diluted to 0.1–0.5 ng/ml. Injected FVB mouse eggs were
transferred into recipient CD1 females and fetuses dissected at
day 15.5. Fetal heads were collected for identification of transgenic
animals by slot or Southern blot hybridization and fetal liver was
split in half for subsequent DNA and RNA analysis from samples
frozen at 280uC.
DNA Analysis
Southern transfer and hybridization were by standard proce-
dures. Copy number determination was performed using a
Molecular Dynamics PhosphorImager (Sunnyvale, CA). Single
copy animals showed a single random-sized end-fragment in
BamHI and EcoRI digests hybridized with the appropriate globin
intron 2 probe. With multicopy animals, the intensity of the end-
fragment was defined as 1 copy and was used to calculate the copy
number of the multicopy junction-fragment in the same lane. The
intactness of the transgene in the DNA sample was verified by
Southern blot analysis using PstI digests hybridized to a 59HS3 or
globin intron 2 probe and an endogenous mTHY-1 probe.
Nonintact transgenes were not included in the calculation of copy
number. A loading control of bred single copy transgenic mouse
DNA included in the PstI Southerns permitted mosaic analysis as
described [12]. Mice that were highly mosaic were excluded from
study after demonstration that ,25% of the fetal liver cells
contained intact transgenes.
Quantitative PCR
We applied real-time SYBR Green PCR and the standard curve
method on an ABI 7900 for analysis of lentiviral copy number, and
for mosaic analysis in transgenic mice taking into account the
transgene copy number deduced by Southern blot analysis. The
product amplified using primers specific for the shared 39 enhancer
region of the transgenes was normalized to the amount of product
amplified with mouse b-actin primers [42]. For each primer pair
(Table 1) a standard curve of 10–10
5 copies was generated using
diluted DNA from BGT50 single copy, bred transgenic mice. Every
PCR reaction was performed induplicate or triplicate ina volume of
20 ml that contained 10 mlo f2 6 SYBR Green reagent (Applied
Biosystems), 0.2 mM of each primer, DNA representing 10
3–10
5
copies of target sequence and H2O. Cycling conditions were
2 minutes at 50uC, 10 minutes at 94uC, [30 seconds at 94uC,
1 minute at 60uC (actin) or 65uC( 3 9 enhancer)]650 cycles. SYBR
Green detection was followed by agarose gel electrophoresis and/or
Melting Curve analysisusing Dissociation Curves software,toensure
that only the target sequence was amplified.
Quantitative RT-PCR
Quantitative reverse transcriptase SYBR Green PCR was used
to estimate Ac-globin expression. Total RNA was obtained using
Trizol reagent (Invitrogen), DNase treated and cDNA synthesized
using Superscript II Reverse Transcriptase (Invitrogen). The
primer pairs used traverse exon junctions. Human hybrid globin
(U01317) primer pair: 62165-62187 F for b-59UTR, and 39762-
39742 R for Ac-Exon 2. Standard curves were generated using
serial dilutions of cDNA from BGT50 single copy, bred transgenic
mice or MEL BGT50 cDNA. Ac-globin expression data were
normalized relative to mouse RNA polymerase II large subunit or
mouse bmajor-globin. Mouse bmajor-globin (J00413.1) primer
pair: 3000-3021F, 3853-3834 R. Mouse RNA polymerase II
largest subunit (RPB1) mRNA (U37500.1): 1694-1714 F and
1783-1761 R. Cycling conditions were 2 minutes at 50uC,
10 minutes at 94uC, [30 seconds at 94uC, 1 minute at 69uC
(human b/c-globin), 65uC (Mouse polymerase II or b-globin)]650
cycles. Specificity of PCR was verified by Melting Curve analysis
using Dissociation Curves software.
Site Specific Integration into MEL Acceptor Cells
MEL acceptor and MEL BGT50 cell lines were described
previously [42] and maintained in DMEM supplemented with
10% heat-inactivated fetal calf serum (FCS), L-glutamine 100 mM,
penicillin 100 mg/ml and streptomycin 292 mg/ml (Invitrogen).
The SFV plasmid is used to deliver LCR b/c-globin sequences to
the genomic FRT site. SFV contains a single FRT site, the
Hygromycin resistance (Hygro) gene and several unique restriction
sites (NotI, BamHI) for cloning. The BGT64, BGT156 and
BGT158 transgenes were subcloned by EcoRV digestion and A-
tailing into pGEM-T Easy, digested with NotI and cloned into the
unique NotI site. Transient transfection of the MEL acceptor cell
line was performed with circular plasmids as described previously
[42]. In brief: 100 mg SFV based BGT156 or BGT158 vectors
were transfected together with 100 mg pEGFP-FLP-C1 (generous
gift of D.E. Sabath) by a single pulse at 260 V and capacitance of
960 mF. Cells were plated 48 h after transfection at different
densities (10
3,1 0
4 per 200 ml in 96-well plates) for selection in
medium containing 500 mg/ml of Hygromycin (Invitrogen). To
identify cell clones with integration into the target FRT site, flow
cytometric analysis was performed to identify cells that do not
express b-galactosidase (b-gal) activity (FACS-GAL) using fluores-
cein di-b-D-galactopyranoside (FDG) as described. Flow cytom-
etry was performed on a FACScan (Becton Dickinson) using
488 nm argon laser excitation and a 525 nm bandpass filter to
detect FITC fluorescence emission and 620 nm bandpass filter to
detect PI fluorescence emission.
Flow Cytometry for Intracellular Ac-Globin Protein
Flow cytometric analysis of Ac-globin expression was performed
as described [67,68]. In brief, 5610
6 MEL cells were suspended in
1 mL HBSS with 4% formaldehyde and incubated at room
temperature for 30 min. Cells were then permeabilized by serial
washes in cold acetone, washed with cold HBSS-2% FBS and
stained with a FITC-conjugated anti-human hemoglobin (c-chain)
monoclonal antibody (Cortex Biochem) for 30 min on ice. The cells
were washed again with HBSS-2% FBS and analyzed by flow
cytometryona FACScan(BD Biosciences)usingCellQuestsoftware.
3D DNA FISH
3D DNA FISH preserves the three dimensional structure of the
nucleus using a protocol adapted from Solovei et al [69]. Slides
were washed with 100% ethanol and 0.1M HCl before coating
with Poly-L-ornithine (Sigma). Cells were washed and left to
attach on Poly-L-ornithine covered slides for 10 min. The cells
were fixed in 4% PFA/PBS for 10 min, quenched with 50 mM
NH4Cl/PBS for 5 min and permeabilized in 0.5% Triton X-100/
PBS for 5 min at RT. Slides were stored in 20% glycerol/PBS
overnight at 4uC before repeated freezing in liquid nitrogen. Slides
were stored in 50% formamide/26 SSC overnight. Cells were
denatured in 70% formamide/26SSC for 5 min. Probes were
labeled with DIG-nick translation mix (Roche), precipitated
overnight with mouse Cot-1 DNA and salmon sperm DNA and
denatured at 95uC for 10 min before addition to denatured cells.
For detection of endogenous mouse b-globin loci, the 189 kb BAC
RP23-370E12 was labeled with DIG-nick translation mix (Roche)
and detected by anti-DIG-rhodamine (Roche, 1/100 dilution).
Probes were hybridized overnight at 37uC. Slides were washed
three times in 50% formamide/50% 26SSC at 42uC and once in
0.56SSC at 62uC. Cells were then blocked in 1% blocking reagent
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labeling step by sheep anti-DIG-POD (Roche, 1/100 dilution) or
rabbit anti-DIG-HRP (DakoCytomation, 1/400 dilution) for
30 min. HRP-conjugated DIG-labeled probes were detected using
Alexa Fluor 546-labeled tyramide (Molecular Probes) [43]. Slides
were washed in 26SSC, counterstained in DAPI and mounted in
antifade.
3D DNA FISH Image Analysis
Images were captured using a Zeiss Axiovert 200M Inverted
Microscope equipped with AxioCam HRm (BGT158, BGT156
and MEL acceptor cell experiments), or with Axiovert 200
Inverted Microscope equipped with a Hamamatsu Orca AG CCD
camera and spinning disk confocal scan head (endogenous b-
globin locus and BGT64 analysis). For each randomly chosen
field, z-sections spaced 0.2 to 0.275 mm apart were collected and
subsequently deconvolved using Axiovision Rel. 4.6 or Volocity.
The z-section containing the FISH signal was analysed to
determine the distance of the transgene relative to the nuclear
periphery, as defined by a sharp drop in DAPI staining. The
distance of the transgene relative to the nuclear periphery was
normalized with the radius of the nucleus at that z-section. From
50 to 170 FISH signals were measured for each experiment and
each experimental condition was repeated at least two times.
ESI Fixation and Embedding
Cells were fixed in 2% paraformaldehyde in PBS for 10 min,
permeabilized in 0.5% Triton-X 100 buffered in PBS and fixed
with 1% glutaraldehyde for 5 min. Cells are rinsed three times
with PBS between treatments. The cells were then dehydrated
with ethanol in steps of 30%, 50%, 70%, 90% and 100% for 30–
90 minutes each. Cells were then embedded in Quetol resin as
previously described [70].
ESI Electron Microscopy
Cells were sectioned to 70 nm in thickness with an ultra
microtome onto copper mesh grids before coating with a 3 nm
carbon film to stabilize sections. Whole nuclei sections and regions
of interest were imaged at 200 kV with a Tecnai 20 (FEI;
Eindhoven, The Netherlands) transmission electron microscope
equipped with a Gatan imaging filter. To measure cell nuclei
size and heterochromatin distribution, phosphorus enhanced
mass images were collected at 155 eV with a CCD camera.
Element-specific images were obtained as described previously
[44]. Phosphorus images were acquired at 120 eV and 155 eV
and nitrogen images with energy loss windows at 385 eV and
415 eV. Images were processed using Digital micrograph software
and Photoshop.
ESI Image Analysis
To assess the impact of HMBA induced differentiation of MEL
cells on nuclear size low magnification phosphorus enhanced mass
images were measured with ImageJ software. Since nuclei were
elliptical in shape, both the long and the short axis were measured
and averaged, and compared between control and differentiated
states. The average diameter of individual axis were calculated,
and compared between treatments. To ascertain the impact of
reduced nuclear size on chromatin distribution in differentiated
cells, ImageJ was used to analyze mass images. The total volume of
peripheral heterochromatin was measured and normalized to the
length of the perimeter, to account for variations in observed
section areas. Qualitative assessments were made of the higher-
resolution element specific ratio maps to assess changes in
chromatin fiber structure and compaction.
Lentiviral Vector Production and Infection
The PL.SIN.cHS4 lentivirus vector was created using PCR and
multiple cloning steps as described in the Supplementary Methods
(Text S1 and Table S1). The LCR b/c-globin transgenes were
isolated as ClaI-EcoRV fragments and inserted in the antisense
orientation into a blunted BamHI and a ClaI site in the lentivirus
vector. Lentivirus vectors were produced in 293-T cells cultured in
Dulbecco’s modified Eagle’s medium (Invitrogen) with 10% fetal
bovine serum (FBS) (Invitrogen). The 293-T cells were plated at a
density of 8610
6 in T-75 flasks. The following day, the cells were
transfected using Lipofectamine 2000 (Invitrogen) with 10 mg
human papillomavirus (HPV) 275 (gag/pol expression plasmid),
10 mg P633 (rev expression plasmid), 10 mg HPV17 (tat expression
plasmid), 5 mg pHCMV-VSV-G (VSV-G expression plasmid) and
15 mg of PL.SIN.cHS4.BGT plasmid. The lentiviruses were
collected in 20 mL media after 48 h, filtered through 0.45 mm
filters and concentrated by ultracentrifugation at 4uC, 2 h,
30,000 rpm with T-865 rotor (Sorvall). The viral pellet was
resuspended to a final volume of 80 ml Hanks’ balanced salt
solution (HBSS, Invitrogen) overnight at 4uC. Next day, 2610
5
murine erythroleukemia (MEL) cells were infected with lentiviruses
at different doses (4, 10 or 40 ml) in the presence of 8 mg/ml
polybrene (Sigma). After 24 h, the medium was replaced with fresh
growth medium. To analyze expression of the Ac-globin, infected
Table 1. Real-time PCR primers
39 Enhancer 41306–41328 F (39 of Ac-Exon3) GGCTGGATTGATTGCAGCTGAGT
64547–64525 R (b 39Enh) GCACCATAAGGGACATGATAAGG
Mouse b-actin NM_007393 694-713 F AGAGGGAAATCGTGCGTGAC
831-815 R CAATAGTGATGACCTGGCCGT
Human hybrid globin U01317 b-59 UTR 62165-62187 F CTAGCAACCTCAAACAGACACC
Ac-exon 2 39762-39742 R GTTGCCCATGATGGCAGAGGC
Mouse b-globin major gene J00413.1 3000-3021 F exon2 TGGGTAATGCCAAAGTGAAGGC
3853-3834 exon3 AATCCTTGCCAAGGTGGTGG
Mouse RNA Pol II (RPB1) U37500.1 1694-1714 F TCACGGCAGTACGCAAATTCA
1783-1761 R CATCCCACGTGGACAGAAACATT
doi:10.1371/journal.pgen.1000051.t001
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mide (HMBA, Aldrich) for 6 days. Virus titers were estimated by
flow cytometry using the formula: NxM/100V, where N is the
numberofMELcellsused forinfection, Mis %expressing cells,and
V is the volume of concentrated virus used for infection (ml).
Supporting Information
Figure S1 The transgene is most frequently proximal to
heterochromatin before induction in MEL BGT158 cells. The
distance of the transgene signal from the nearest DAPI-rich
heterochromatin was measured in a z-section. Proximity is
arbitrarily defined as being within 1 mm of heterochromatin.
Found at: doi:10.1371/journal.pgen.1000051.s001 (0.55 MB TIF)
Figure S2 Characterization of MEL cell induction using surface
markers of erythroid development. Uninduced and 3 day HMBA
treated MEL cells were stained with the following antibodies to
detect early (CD117), intermediate (Ery1 and CD71) and late
stages (Ter119) of erythroid development. Positive controls include
E12.5 mouse fetal liver and Primary Bone Marrow Mastocytes.
Method: MEL cells were washed with cold HBSS-2% FBS and
stained with a PE-conjugated anti-CD117 (BD Pharmingen Cat.
#553355) provided by D. Barber or FITC-conjugated anti-CD71
(BD Pharmingen Cat. #553266), or PE-conjugated anti-Ter119
(BD Pharmingen Cat. #553673) for 30 min on ice, or anti-Ery1
antibody (Bacon and Sytkowski 1987, Blood 69:103-108) which was
followed by an Alexa Fluor 488 goat anti-rat IgG (Molecular
Probes A-11006). The cells were washed again with HBSS-2%
FBS and analyzed by flow cytometry on a FACScan (BD
Biosciences) using CellQuest software. Primary Bone Marrow
Mastocytes (BMMC) cells provided by S. Berger were used as
positive controls for anti-CD117 antibody and were maintained in
Opti-MEM supplemented with 5% FBS, 6% WEHI conditioned
medium containing IL-3 and 55 mM beta-mercaptoethanol. As
positive controls for anti-CD71, anti-Ter119 and Ery1 antibodies,
we used freshly isolated mouse fetal liver cells from E12.5 embryos.
Found at: doi:10.1371/journal.pgen.1000051.s002 (1.12 MB TIF)
Figure S3 The cHS4 dimer core recombines into a monomer
after lentivirus transfer. PCR amplification using primers that
overlap the insulator-LTR junctions demonstrates presence of a
monomer cHS4 core element.
LTR cHS4
Forward cHS4 primer 59-TCCCAAAGAAGACAAGATGTCG
LTR cHS4
Reverse cHS4 primer 59-GTACAGGCAAAAAGCAGGTCGAAGC
Found at: doi:10.1371/journal.pgen.1000051.s003 (5.44 MB TIF)
Table S1 List of primer sequences used in PCR reactions for
construction of LCR b/c-globin transgenes and lentiviral vectors.
Found at: doi:10.1371/journal.pgen.1000051.s004 (0.03 MB
DOC)
Text S1 Supplementarty methods
Found at: doi:10.1371/journal.pgen.1000051.s005 (0.04 MB
DOC)
Video S1 Example 3D DNA FISH reconstruction of transgene
localization in uninduced MEL BGT158 cells. The transgene is
detected as a red signal by a 10 kb DIG labeled probe using Alexa
Fluor 546 labeled tyramide signal amplification with DAPI
counterstained nuclear DNA in green. DAPI-rich areas corre-
spond to heterochromatin.
Found at: doi:10.1371/journal.pgen.1000051.s006 (5.06 MB
MOV)
Acknowledgments
WethankMargaretBentoandPinayKainthforhelpgenerating59HS3b/c-
globin transgene constructs, Tanya Sukonnik for assistance with lentivirus
infections, Cameron Osborne for advice on 3DDNAFISH,TerumiKohwi-
Shigematsu for advice on tyramide signal amplication, and Mengshu Xu for
assistance in measuring transgene localization. Advice on Ac-globin flow
cytometry was provided by David Emery, and the protocol for two step
lentivirusconcentrationwas from Leszek Lisowski andMichel Sadelain. The
lentivirus backbone with the wild-type 39LTR and packaging plasmids were
kindly provided by Philippe Leboulch. We gratefully acknowledge the
assistance of Linda Wei in the SickKids Transgenic Mouse Facility, Sherry
Zhau for FACS sorting cells in the SickKids Flow Cytometry Facility, Mike
Woodside and Paul Paroutis in the SickKids Imaging Facility, and the
SickKids TCAG Sequencing Facility.
Author Contributions
Conceived and designed the experiments: AB JG DB JE. Performed the
experiments: AB ML AM AH EF RB PP. Analyzed the data: AB ML AM
AH JG JE. Wrote the paper: AB ML EF JE.
References
1. Wijgerde M, Grosveld F, Fraser P (1995) Transcription complex stability and
chromatin dynamics in vivo. Nature 377: 209–213.
2. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W (2002) Looping and
interaction between hypersensitive sites in the active beta-globin locus. Mol Cell
10: 1453–1465.
3. Palstra RJ, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, et al. (2003) The
beta-globin nuclear compartment in development and erythroid differentiation.
Nat Genet 35: 190–194.
4. Patrinos GP, de Krom M, de Boer E, Langeveld A, Imam AM, et al. (2004)
Multiple interactions between regulatory regions are required to stabilize an
active chromatin hub. Genes Dev 18: 1495–1509.
5. Carter D, Chakalova L, Osborne CS, Dai YF, Fraser P (2002) Long-range
chromatin regulatory interactions in vivo. Nat Genet 32: 623–626.
6. Osborne CS, Chakalova L, Brown KE, Carter D, Horton A, et al. (2004) Active
genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet
36: 1065–1071.
7. Francastel C, Walters MC, Groudine M, Martin DI (1999) A functional
enhancer suppresses silencing of a transgene and prevents its localization close to
centrometric heterochromatin. Cell 99: 259–269.
8. RagoczyT,BenderMA,TellingA,ByronR,GroudineM(2006)Thelocuscontrol
region is required for association of the murine beta-globin locus with engaged
transcription factories during erythroid maturation. Genes Dev 20: 1447–1457.
9. Bender MA, Bulger M, Close J, Groudine M (2000) Beta-globin gene switching
and DNase I sensitivity of the endogenous beta-globin locus in mice do not
require the locus control region. Mol Cell 5: 387–393.
10. Grosveld F, van Assendelft GB, Greaves DR, Kollias G (1987) Position-
independent, high-level expression of the human beta-globin gene in transgenic
mice. Cell 51: 975–985.
11. Talbot D, Collis P, Antoniou M, Vidal M, Grosveld F, et al. (1989) A dominant
control region from the human beta-globin locus conferring integration site-
independent gene expression. Nature 338: 352–355.
12. Pasceri P, Pannell D, Wu X, Ellis J (1998) Full activity from human beta-globin
locus control region transgenes requires 59HS1, distal beta-globin promoter and
39 beta-globin sequences. Blood 92: 653–663.
13. Ellis J, Tan-Un KC, Harper A, Michalovich D, Yannoutsos N, et al. (1996) A
dominant chromatin-opening activity in 59 hypersensitive site 3 of the human
beta-globin locus control region. EMBO Journal 15: 562–568.
14. Rivella S, May C, Chadburn A, Riviere I, Sadelain M (2003) A novel murine
model of Cooley anemia and its rescue by lentiviral-mediated human beta-
globin gene transfer. Blood 101: 2932–2939.
15. May C, Rivella S, Callegari J, Heller G, Gaensler KM, et al. (2000) Therapeutic
haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded
human beta-globin. Nature 406: 82–86.
16. May C, Rivella S, Chadburn A, Sadelain M (2002) Successful treatment of
murine beta-thalassemia intermedia by transfer of the human beta-globin gene.
Blood 99: 1902–1908.
17. Samakoglu S, Lisowski L, Budak-Alpdogan T, Usachenko Y, Acuto S, et al.
(2006) A genetic strategy to treat sickle cell anemia by coregulating
globin transgene expression and RNA interference. Nat Biotechnol 24:
89–94.
Intron Elements Potentiate LCR Activity
PLoS Genetics | www.plosgenetics.org 16 April 2008 | Volume 4 | Issue 4 | e100005118. Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, et al. (2001)
Correction of sickle cell disease in transgenic mouse models by gene therapy.
Science 294: 2368–2371.
19. Hanawa H, Persons DA, Nienhuis AW (2002) High-level erythroid lineage-
directed gene expression using globin gene regulatory elements after lentiviral
vector-mediated gene transfer into primitive human and murine hematopoietic
cells. Hum Gene Ther 13: 2007–2016.
20. Levasseur DN, Ryan TM, Pawlik KM, Townes TM (2003) Correction of a
mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene
transduction of unmobilized, purified hematopoietic stem cells. Blood 102:
4312–4319.
21. Imren S, Fabry ME, Westerman KA, Pawliuk R, Tang P, et al. (2004) High-
level beta-globin expression and preferred intragenic integration after lentiviral
transduction of human cord blood stem cells. J Clin Invest 114: 953–962.
22. Leboulch P, Huang GM, Humphries RK, Oh YH, Eaves CJ, et al. (1994)
Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-
globin locus control region derivatives results in stable transmission of an active
transcriptional structure. EMBO Journal 13: 3065–3076.
23. Sadelain M, Wang CH, Antoniou M, Grosveld F, Mulligan RC (1995)
Generation of a high-titer retroviral vector capable of expressing high levels of
the human beta-globin gene. Proc Natl Acad Sci U S A 92: 6728–6732.
24. Rubin JE, Pasceri P, Wu X, Leboulch P, Ellis J (2000) Locus control region
activity by 59HS3 requires a functional interaction with beta-globin gene
regulatory elements: expression of novel beta/gamma-globin hybrid transgenes.
Blood 95: 3242–3249.
25. Persons DA, Hargrove PW, Allay ER, Hanawa H, Nienhuis AW (2003) The
degree of phenotypic correction of murine beta -thalassemia intermedia
following lentiviral-mediated transfer of a human gamma-globin gene is
influenced by chromosomal position effects and vector copy number. Blood
101: 2175–2183.
26. Imren S, Payen E, Westerman KA, Pawliuk R, Fabry ME, et al. (2002)
Permanent and panerythroid correction of murine beta thalassemia by multiple
lentiviral integration in hematopoietic stem cells. Proc Natl Acad Sci U S A 99:
14380–14385.
27. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N,
et al. (2003) LMO2-associated clonal T cell proliferation in two patients after
gene therapy for SCID-X1. Science 302: 415–419.
28. Rivella S, Callegari JA, May C, Tan CW, Sadelain M (2000) The cHS4
insulator increases the probability of retroviral expression at random
chromosomal integration sites. J Virol 74: 4679–4687.
29. Emery DW, Yannaki E, Tubb J, Nishino T, Li Q, et al. (2002) Development of
virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a
chromatin insulator reduces gamma-globin gene silencing in vivo. Blood 100:
2012–2019.
30. Yao S, Osborne CS, Bharadwaj RR, Pasceri P, Sukonnik T, et al. (2003)
Retrovirus silencer blocking by the cHS4 insulator is CTCF independent.
Nucleic Acids Res 31: 5317–5323.
31. Puthenveetil G, Scholes J, Carbonell D, Qureshi N, Xia P, et al. (2004)
Successful correction of the human beta-thalassemia major phenotype using a
lentiviral vector. Blood 104: 3445–3453.
32. Arumugam PI, Scholes J, Perelman N, Xia P, Yee JK, et al. (2007) Improved
Human beta-globin Expression from Self-inactivating Lentiviral Vectors
Carrying the Chicken Hypersensitive Site-4 (cHS4) Insulator Element. Mol
Ther 15: 1863–1871.
33. Ellis J, Pannell D (2001) The beta-globin locus control region versus gene
therapy vectors: a struggle for expression. Clin Genet 59: 17–24.
34. Bharadwaj RR, Trainor CD, Pasceri P, Ellis J (2003) LCR-regulated transgene
expression levels depend on the Oct-1 site in the AT-rich region of beta -globin
intron-2. Blood 101: 1603–1610.
35. Jackson CE, Neill DO, Bank A (1995) Nuclear Factor Binding Sites in Human
beta Globin IVS2. J Biol Chem 270: 28448–28456.
36. Wang VE, Schmidt T, Chen J, Sharp PA, Tantin D (2004) Embryonic lethality,
decreased erythropoiesis, and defective octamer-dependent promoter activation
in Oct-1-deficient mice. Mol Cell Biol 24: 1022–1032.
37. Jarman AP, Higgs DR (1988) Nuclear scaffold attachment sites in the human
globin gene complexes. EMBO J 7: 3337–3344.
38. Ostermeier GC, Liu Z, Martins RP, Bharadwaj RR, Ellis J, et al. (2003) Nuclear
matrix association of the human beta-globin locus utilizing a novel approach to
quantitative real-time PCR. Nucleic Acids Res 31: 3257–3266.
39. Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T, et al. (2005)
SATB1 family protein expressed during early erythroid differentiation modifies
globin gene expression. Blood 105: 3330–3339.
40. Jenuwein T, Forrester WC, Fernandez-Herrero LA, Laible G, Dull M, et al.
(1997) Extension of chromatin accessibility by nuclear matrix attachment
regions. Nature 385: 269–272.
41. Lutzko C, Senadheera D, Skelton D, Petersen D, Kohn DB (2003) Lentivirus
vectors incorporating the immunoglobulin heavy chain enhancer and matrix
attachment regions provide position-independent expression in B lymphocytes.
J Virol 77: 7341–7351.
42. Buzina A, Aladjem MI, Kolman JL, Wahl GM, Ellis J (2005) Initiation of DNA
replication at the human beta-globin 39 enhancer. Nucleic Acids Res 33:
4412–4424.
43. Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture
and gene expression regulated by SATB1. Nat Genet 34: 42–51.
44. Dehghani H, Dellaire G, Bazett-Jones DP (2005) Organization of chromatin in
the interphase mammalian cell. Micron 36: 95–108.
45. Lisowski L, Sadelain M (2007) Locus control region elements HS1 and HS4
enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic
mice. Blood 110: 4175–4178.
46. Ellis J, Pasceri P, Tan-Un KC, Wu X, Harper A, et al. (1997) Evaluation of beta-
globin gene therapy constructs in single copy transgenic mice. Nucleic Acids Res
25: 1296–1302.
47. Antoniou M, deBoer E, Habets G, Grosveld F (1988) The human beta-globin
gene contains multiple regulatory regions: identification of one promoter and
two downstream enhancers. EMBO Journal 7: 377–384.
48. Rodriguez P, Bonte E, Krijgsveld J, Kolodziej KE, Guyot B, et al. (2005)
GATA-1 forms distinct activating and repressive complexes in erythroid cells.
EMBO J 24: 2354–2366.
49. Letting DL, Chen YY, Rakowski C, Reedy S, Blobel GA (2004) Context-
dependentregulationofGATA-1byfriendofGATA-1.ProcNatlAcad SciUSA
101: 476–481.
50. Liu LR, Du ZW, Zhao HL, Liu XL, Huang XD, et al. (2005) T to C substitution
at -175 or -173 of the gamma -globin promoter affects GATA-1 and Oct-1
binding in vitro differently, but can independently reproduce HPFH phenotype
in transgenic mice. J Biol Chem 280: 7452–7459.
51. Fernandez LA, Winkler M, Grosschedl R (2001) Matrix attachment region-
dependent function of the immunoglobulin mu enhancer involves histone
acetylation at a distance without changes in enhancer occupancy. Mol Cell Biol
21: 196–208.
52. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (2002)
SATB1 targets chromatin remodelling to regulate genes over long distances.
Nature 419: 641–645.
53. Cai S, Lee CC, Kohwi-Shigematsu T (2006) SATB1 packages densely looped,
transcriptionally active chromatin for coordinated expression of cytokine genes.
Nat Genet 38: 1278–1288.
54. Horike S, Cai S, Miyano M, Cheng JF, Kohwi-Shigematsu T (2005) Loss of
silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
Nat Genet 37: 31–40.
55. Wang L, Lin CM, Brooks S, Cimbora D, Groudine M, et al. (2004) The human
beta-globin replication initiation region consists of two modular independent
replicators. Mol Cell Biol 24: 3373–3386.
56. Ariizumi K, Wang Z, Tucker PW (1993) Immunoglobulin heavy chain enhancer
is located near or in an initiation zone of chromosomal DNA replication. Proc
Natl Acad Sci U S A 90: 3695–3699.
57. Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, et al. (2007) Functional
interaction between PML and SATB1 regulates chromatin-loop architecture
and transcription of the MHC class I locus. Nat Cell Biol 9: 45–56.
58. Splinter E, Heath H, Kooren J, Palstra RJ, Klous P, et al. (2006) CTCF mediates
long-range chromatin looping and local histone modification in the beta-globin
locus. Genes Dev 20: 2349–2354.
59. Herrscher RF, Kaplan MH, Lelsz DL, Das C, Scheuermann R, et al. (1995) The
immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a
B cell-specific trans-activator that describes a new DNA-binding protein family.
Genes Dev 9: 3067–3082.
60. Francastel C, Magis W, Groudine M (2001) Nuclear relocation of a
transactivator subunit precedes target gene activation. Proc Natl Acad
Sci U S A 98: 12120–12125.
61. Talbot D, Grosveld F (1991) The 59HS2 of the globin locus control region
enhances transcription through the interaction of a multimeric complex binding
at two functionally distinct NF-E2 binding sites. EMBO Journal 10: 1391–1398.
62. Pruzina S, Antoniou M, Hurst J, Grosveld F, Philipsen S (1994) Transcriptional
activation by hypersensitive site three of the human beta-globin locus control
region in murine erythroleukemia cells. Biochimica et Biophysica Acta 1219:
351–360.
63. Brand M, Ranish JA, Kummer NT, Hamilton J, Igarashi K, et al. (2004)
Dynamic changes in transcription factor complexes during erythroid differen-
tiation revealed by quantitative proteomics. Nat Struct Mol Biol 11: 73–80.
64. Kooren J, Palstra RJ, Klous P, Splinter E, von Lindern M, et al. (2007) Beta-
globin active chromatin Hub formation in differentiating erythroid cells and in
p45 NF-E2 knock-out mice. J Biol Chem 282: 16544–16552.
65. Drissen R, Palstra RJ, Gillemans N, Splinter E, Grosveld F, et al. (2004) The
active spatial organization of the beta-globin locus requires the transcription
factor EKLF. Genes Dev 18: 2485–2490.
66. Vakoc CR, Letting DL, Gheldof N, Sawado T, Bender MA, et al. (2005)
Proximity among Distant Regulatory Elements at the beta-Globin Locus
Requires GATA-1 and FOG-1. Mol Cell 17: 453–462.
67. Thorpe SJ, Thein SL, Sampietro M, Craig JE, Mahon B, et al. (1994)
Immunochemical estimation of haemoglobin types in red blood cells by FACS
analysis. Br J Haematol 87: 125–132.
68. Fragkos M, Anagnou NP, Tubb J, Emery DW (2005) Use of the hereditary
persistence of fetal hemoglobin 2 enhancer to increase the expression of
oncoretrovirus vectors for human gamma-globin. Gene Ther 12: 1591–1600.
69. Solovei I, Cavallo A, Schermelleh L, Jaunin F, Scasselati C, et al. (2002) Spatial
preservation of nuclear chromatin architecture during three-dimensional
fluorescence in situ hybridization (3D-FISH). Exp Cell Res 276: 10–23.
70. Bazett-Jones DP, Hendzel MJ, Kruhlak MJ (1999) Stoichiometric analysis of
protein- and nucleic acid-based structures in the cell nucleus. Micron 30:
151–157.
Intron Elements Potentiate LCR Activity
PLoS Genetics | www.plosgenetics.org 17 April 2008 | Volume 4 | Issue 4 | e1000051